Dorsey & Whitney Trust CO LLC Decreases Stock Holdings in Lam Research Corporation $LRCX

Dorsey & Whitney Trust CO LLC reduced its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 15.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 10,597 shares of the semiconductor company’s stock after selling 1,901 shares during the quarter. Dorsey & Whitney Trust CO LLC’s holdings in Lam Research were worth $1,032,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Empowered Funds LLC grew its stake in shares of Lam Research by 10.5% in the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after buying an additional 17,833 shares in the last quarter. Genus Capital Management Inc. bought a new position in shares of Lam Research in the 2nd quarter valued at about $14,476,000. Cookson Peirce & Co. Inc. purchased a new position in Lam Research in the first quarter worth about $607,000. Sava Infond d.o.o. grew its position in Lam Research by 3.1% in the second quarter. Sava Infond d.o.o. now owns 75,250 shares of the semiconductor company’s stock worth $7,325,000 after acquiring an additional 2,250 shares in the last quarter. Finally, Glass Wealth Management Co LLC increased its stake in Lam Research by 8.5% during the second quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after acquiring an additional 2,270 shares during the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 102,608 shares of company stock worth $14,916,496 in the last ninety days. 0.31% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on LRCX shares. JPMorgan Chase & Co. raised their price objective on Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday, October 23rd. Needham & Company LLC raised their price target on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Oppenheimer set a $200.00 target price on shares of Lam Research and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, The Goldman Sachs Group lifted their price target on shares of Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $149.04.

Lam Research Stock Down 2.9%

Shares of LRCX opened at $143.24 on Wednesday. The firm has a fifty day moving average price of $142.35 and a 200-day moving average price of $110.96. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $179.91 billion, a P/E ratio of 31.55, a P/E/G ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $167.15.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm’s revenue for the quarter was up 27.7% on a year-over-year basis. During the same quarter last year, the business posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s payout ratio is presently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.